GLOW Blend 70mg Vial

70 £

Out of Stock

Out of stock

3ml of bacteriostatic water included

GLOW Blend (70 mg total peptide content)

Label composition:

10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu

Overview:

This blend combines three investigational peptides commonly studied for their

potential roles in tissue repair, regeneration, and extracellular matrix support.

The formulation appears designed to target complementary biological

pathways involved in healing and skin-related research models.

Component Breakdown & Research Context

BPC-157 (10 mg)

Research Focus:

Most available evidence comes from preclinical studies. Human clinical data

remain limited.

TB-500 (10 mg)

(Synthetic fragment of Thymosin Beta-4)

Research Focus:

Preclinical research suggests a role in wound healing and muscle repair.

Robust

large-scale human trials are lacking.

GHK-Cu (50 mg)

(Copper tripeptide complex)

Research Focus:

Among the three components, GHK-Cu has comparatively more documentation

in topical cosmetic research.

Theoretical Rationale for Combination

In research settings, combining these peptides may be intended to:

However, there are no large-scale clinical trials evaluating this specific

combination as a standardized therapeutic formulation.

Evidence & Regulatory Status

All three components are considered investigational in most regions.
The combination product itself has not undergone formal regulatory approval processes.
Long-term safety and efficacy data for combined systemic use are limited.
Products labeled “for research use only” are not equivalent to approved pharmaceutical products.

FOR RESEARCH USE ONLY